Wilson Sonsini Goodrich & Rosati represented Dewpoint Therapeutics in the transaction. Dewpoint Therapeutics Inc., the leading biotechnology company that develops therapeutics by targeting biomolecular condensates, announced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Socure on the transaction. Socure, the leading provider of artificial intelligence for digital identity verification, fraud prevention, and sanction screening,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aembit on the transaction. Aembit, a leading non-human identity and access management (IAM) company, has secured $25 million in Series...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Fluent Biosciences on the transaction. Illumina, Inc. (NASDAQ: ILMN) announced it has acquired Fluent BioSciences (Fluent), developer of an emerging...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised TravelPerk on the transaction, and Bradley Arant Boult Cummings advised AmTrav. TravelPerk announced its acquisition of the industry-leading United States...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Frequence on the transaction, and Latham & Watkins advised Madhive. Madhive, the leading technology company for local Connected Television advertising...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Block on the offering, and Simpson Thacher & Bartlett advised the initial purchasers. Block, Inc. (NYSE: SQ) (“Block” or the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aledade on the transaction. Aledade, the nation’s largest and most successful network of physician-led value-based care, announced that it has...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Pu’er Lancang Ancient Tea Co., Ltd. on the offering. Pu’er Lancang Ancient Tea Co., Ltd. (Pu’er Lancang) (Lancang Tea, stock...
You must be a Standard 1 Year member to access this content.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Amring Pharmaceuticals Inc. on the transaction, and Wilson Sonsini Goodrich & Rosati advised Visant Medical. Amring Pharmaceuticals Inc....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented IVIVA in the transaction. United Therapeutics (Nasdaq:UTHR) announced it acquisition of all of the outstanding equity of IVIVA Medical, Inc., a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati is representing LENZ Therapeutics in the transaction, Goodwin Procter is representing Graphite Bio and Latham & Watkins is representing the placements...
You must be a Standard 1 Year member to access this content.
